|
Utilize protein markers and genomic features for minimal residual disease detection in hepatocellular carcinoma. |
| |
|
No Relationships to Disclose |
| |
|
|
|
| |
|
No Relationships to Disclose |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
Employment - Clinical Laboratories, Shenyou Bio |
Honoraria - Clinical Laboratories, Shenyou Bio |
| |
|
No Relationships to Disclose |
| |
|
Employment - Clinical Laboratories, Shenyou Bio |
Honoraria - Clinical Laboratories, Shenyou Bio |
| |
|
Employment - Clinical Laboratories, Shenyou Bio |
Honoraria - Clinical Laboratories, Shenyou Bio |
| |
|
|
|
Stock and Other Ownership Interests - SeekIn |
|
Patents, Royalties, Other Intellectual Property - Hepatocellular carcinoma screening (Inst) |